Evaluating Efficacy of White Paraffin with Oral Methotrexate versus Siddharthaka Snana Ointment with Oral Guduchi Ghrita in Ekakushtha (Psoriasis): A Randomised Clinical Trial Research Protocol

Read full text Summarise with VIRAT
Authors: Sourabh Deshmukh, Vaishali Vasantrao Kuchewar
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Introduction: Psoriasis is a chronic, immune-mediated inflammatory disorder that primarily affects the skin and joints, with a global prevalence ranging between 1% and 3%. It is characterised by erythematous plaques covered with silverywhite scales, resulting from hyperproliferation and dysregulated differentiation of keratinocytes. Psoriasis in Ayurveda can be linked with Ekakushta. Need for study: Methotrexate is widely used for psoriasis but limited by long-term side-effects like hepatotoxicity and Gastrointestinal (GI) discomfort. This calls for safer alternatives. An Ayurvedic approach using Siddharthaka Snana ointment and Guduchi Ghrita shows promise. The ointment form enhances skin application and compliance, while Guduchi offers immunomodulatory and hepatoprotective benefits. Ghrita improves its bioavailability and shelf life. Evaluating this combination may offer a safer, effective, and sustainable option for psoriasis management. Aim: Evaluation of comparative efficacy of white paraffin with oral methotrexate versus Siddharthaka Snana ointment with oral Guduchi Ghrita in Ekakushtha (Psoriasis). Materials and Methods: A randomised controlled trial will be conducted at Mahatma Gandhi Ayurved College Hospital and Research Centre, Salod (H), Wardha, Maharashtra India, from February 2024 to December 2026. The patients will be split into two categories: A, Group A: Trial group (Siddharthaka Snana Ointment with Oral Guduchi Ghrita) and Group B: control group(Liquid paraffin and oral Methotrexate). Laboratory investigations such as complete blood count, erythrocyte sedimentation rate, and random blood sugar will be assessed on the 0th day. Moreover, liver function test will be assessed on 0th, 7th, 15th, and 60th day. The objective parameters candle grease sign, Auspitz sign, and Psoriasis Area and Severity Index (PASI) score and subjective parameters Aswedadanam, Mahavastum, Matsyashaklopamam, Krishna Arun Varna, Dermatology Life Quality Index (DLQI) and Psoriasis Disability Index (PDI) will be assessed on at baseline, 7th, 15th, 30th, 45th and 60th day. The Kolmogorov-Smirnov test will be used to determine whether continuous data has a normal distribution. The Wilcoxon rank test will be applied alternately for non-normal distribution. A p-value

Fields of Study & Subjects

Psoriasis: Treatment and Pathogenesis Traditional Chinese Medicine Studies Dermatology and Skin Diseases

Publication details

Journal / source
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
Publication date
18 March 2026
Language
EN